EGFR and cancer: For example, the ErbB pathway downregulates the chemokine ligand CXCL10 through PI3K–AKT signaling and interferon regulatory factor IRF1, which results in the reduction of effector CD8+ T cells and recruitment of Treg cells into the tumor microenvironment; this leads to immune escape and cancer growth [46].